Cite
HARVARD Citation
Xu, J. et al. (2020). A Phase II Trial of Cabozantinib in Hormone Receptor‐Positive Breast Cancer with Bone Metastases. Oncologist. pp. 652-660. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Xu, J. et al. (2020). A Phase II Trial of Cabozantinib in Hormone Receptor‐Positive Breast Cancer with Bone Metastases. Oncologist. pp. 652-660. [Online].